Cleared Traditional

K921313 - AEROSTAR

K921313 is an FDA 510(k) clearance for AEROSTAR, manufactured by Biosafety Systems, Inc.. The device is a Class 2 Anesthesiology device with product code CBN cleared through the Traditional 510(k) pathway after a 177-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1992
Decision
177d
Days
Class 2
Risk

K921313 is an FDA 510(k) clearance for the AEROSTAR. Classified as Apparatus, Gas-scavenging (product code CBN), Class II - Special Controls.

Submitted by Biosafety Systems, Inc. (San Diego, US). The FDA issued a Cleared decision on September 11, 1992 after a review of 177 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5430 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K921313

510(k) Number K921313 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 18, 1992
Decision Date September 11, 1992
Days to Decision 177 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
37d slower than avg
Panel avg: 140d · This submission: 177d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CBN Device Classification - Class 2, Special Controls

Product Code CBN Apparatus, Gas-scavenging
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5430
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CBN Apparatus, Gas-scavenging

All 42
Devices cleared under the same product code (CBN) and FDA review panel - the closest regulatory comparables to K921313.
AES, (ANESCO EVACUATION SYSTEM) ACTIVE WASTE ANESTHETIC GAS EVACUATION SYSTEM
K945216 · Anesco · Sep 1995
AIRES
K920043 · Viva-Tek Assoc., Inc. · Jun 1993
ISOL-AIDE
K915287 · Computronic Systems · Oct 1992
CAP-EVAC ADAPTER
K904803 · Logan, Inc. · Nov 1990
DEMISTIFIER ISOLATION CHAMBER
K902161 · Peace Medical, Inc. · Oct 1990
TECH MED NITROUS OXIDE SEDATION NASAL INHALER CIR.
K896510 · Technical Medical Products, Inc. · Jan 1990